Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:CPI-905 CAS:931078-17-0 Package:25mg/RMB 10600;100mg/RMB 17500;50mg/RMB 13800
|
|
| 1,4-Benzodioxin-6-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-2,3-dihydro-8-methoxy- Basic information |
Product Name: | 1,4-Benzodioxin-6-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-2,3-dihydro-8-methoxy- | Synonyms: | 1,4-Benzodioxin-6-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-2,3-dihydro-8-methoxy-;CPI 905;CPI905;CPI-905 | CAS: | 931078-17-0 | MF: | C18H20N2O5 | MW: | 344.36 | EINECS: | | Product Categories: | | Mol File: | 931078-17-0.mol | |
| 1,4-Benzodioxin-6-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-2,3-dihydro-8-methoxy- Chemical Properties |
Boiling point | 548.8±50.0 °C(Predicted) | density | 1.237±0.06 g/cm3(Predicted) | pka | 11.89±0.10(Predicted) |
| 1,4-Benzodioxin-6-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-2,3-dihydro-8-methoxy- Usage And Synthesis |
Description | CPI-905 is a potent and selective EZH2 inhibitor (IC50 = 39.5 nM). The histone lysine methyltransferase (MT) Enhancer of Zeste Homolog 2 (EZH2) is considered an oncogenic driver in a subset of germinal center B-celllike diffuse large B cell lymphoma (GCB-DLBCL) and follicular lymphoma due to the presence of recurrent, monoallelic mutations in the EZH2 catalytic domain. . |
| 1,4-Benzodioxin-6-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-2,3-dihydro-8-methoxy- Preparation Products And Raw materials |
|